October 9, 2025Frontiers in PharmacologyOpen Access

Yiqi Gubiao Pill for tuberculosis-associated obstructive pulmonary disease: protocol for a double-blind randomized controlled trial

View Full Paper

Ask AI

Bookmark

The trial assesses the effectiveness of Yiqi Gubiao Pill for treating tuberculosis-associated obstructive pulmonary disease.
A total of 12 weeks of treatment with Yiqi Gubiao Pill or placebo will be administered, with pulmonary function evaluations included.
The double-blind randomized controlled trial design ensures unbiased results to evaluate the pill's efficacy and safety.
Positive outcomes may provide a new treatment strategy for patients suffering from tuberculosis-associated obstructive pulmonary disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Protocol for a randomized controlled trial assessing Yiqi Gubiao Pill for tuberculosis-associated obstructive pulmonary disease, indicating important safety measures.

Cite This Study

Dai et al. (2025) studied this question.

synapsesocial.com/papers/68e7ba40ccde5f1021f64a88 https://doi.org/10.3389/fphar.2025.1610889

View Full Paper

Ask AI

Bookmark

Implication

Protocol for a randomized controlled trial assessing Yiqi Gubiao Pill for tuberculosis-associated obstructive pulmonary disease, indicating important safety measures.

Yiqi Gubiao Pill for tuberculosis-associated obstructive pulmonary disease: protocol for a double-blind randomized controlled trial

Key Points

Discussion

Implication

Cite This Study

Yiqi Gubiao Pill for tuberculosis-associated obstructive pulmonary disease: protocol for a double-blind randomized controlled trial

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading